Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

1.0K
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.0K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

16
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
16
Vaccinations01:51

Vaccinations

53.5K
Overview
53.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA-E-restricted T cells primed by a modified HLA-B*57:01 restricted HIV-1 peptide suppress HIV-1 replication.

JCI insight·2026
Same author

Nonclassical MHC-I Molecules: Emerging Therapeutic Targets in Next-Generation Immunotherapy.

MedComm·2026
Same author

Shared HLA-E and Mamu-E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF- and Fluorescence Polarisation-Based Methods.

European journal of immunology·2026
Same author

A cytoplasmic motif in HLA-E that drives clathrin-mediated endocytosis and VCP-associated postendocytic trafficking.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Targeting MHC-E as a new strategy for vaccines and immunotherapeutics.

Nature reviews. Immunology·2025
Same author

HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies.

Immunological reviews·2025

Related Experiment Video

Updated: Mar 25, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

16.3K

HIV-Host Interactions: Implications for Vaccine Design.

Barton F Haynes1, George M Shaw2, Bette Korber3

  • 1Department of Medicine, Duke University, Durham, NC 27710, USA; Department of Immunology, Duke University, Durham, NC 27710, USA; Duke University Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Cell Host & Microbe
|March 1, 2016
PubMed
Summary
This summary is machine-generated.

Developing an effective AIDS vaccine remains a global challenge due to HIV-1's diversity and host immune factors. New strategies show promise, but further understanding of virus-host interactions is crucial for success.

More Related Videos

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
13:13

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques

Published on: September 25, 2018

11.2K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K

Related Experiment Videos

Last Updated: Mar 25, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

16.3K
Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
13:13

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques

Published on: September 25, 2018

11.2K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.8K

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Developing an effective AIDS vaccine is a global priority.
  • Extreme human immunodeficiency virus type 1 (HIV-1) diversity and host factors hinder protective immune responses, impeding vaccine development.
  • Previous research has identified challenges including viral mutation to escape immunity.

Purpose of the Study:

  • To review recent breakthroughs in HIV-1 biology and immunology relevant to vaccine development.
  • To discuss novel vaccine strategies arising from new scientific insights.
  • To highlight the ongoing need for understanding virus-host interactions for successful vaccine design.

Main Methods:

  • Review of recent scientific literature and preclinical trial data.
  • Analysis of advancements in understanding HIV-1 envelope trimer structure and transmitted virus biology.
  • Evaluation of insights into vaccine-induced CD8 T cell control and antibody elicitation.

Main Results:

  • Significant progress has been made in understanding HIV-1 envelope trimer structure and transmitted virus biology.
  • New insights into CD8 T cell control in primates and antibody elicitation offer novel vaccine strategies.
  • Preclinical data underscore the complexity of eliciting protective immunity.

Conclusions:

  • Despite promising new vaccine strategies, the extreme diversity of HIV-1 and host immune responses remain significant hurdles.
  • Further research into virus-host biology is essential to overcome challenges and develop an effective AIDS vaccine.
  • Continued investigation into viral evasion mechanisms and host immune control is critical for future vaccine efficacy.